Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atazanavir vs Lopinavir/Ritonavir in HIV Virologic Failure
NCT00028301Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2001
- Primary completion
- Sep 2003
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Started Feb 2001; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00028301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028301.